Gabapentinoids appear increasingly to be prescribed, off-label, for cancer pain

Between 2005 and 2015, as the opioid crisis in America came into focus, prescriptions for gabapentinoid medications -- gabapentin and pregabalin -- to adults with cancer saw a two-fold increase, a new study has found.